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SURVIVAL TRENDS IN ELDERLY DIALYSIS
PATIENTS AND THE GENERAL POPULATION
AG RITCHIE1,2, PA CLAYTON2,3
1Concord Hospital, Sydney, NSW; 2Sydney Medical School, Sydney, NSW;
3ANZDATA Registry, Adelaide, South Australia, Australia
Aim: To identify survival trends in elderly dialysis patients compared with the
general population.
Background: Elderly dialysis patients are the most rapidly growing segment in
Australia and survival appears to be improving, but the trends and relationship to
general population survival have not been recently assessed.
Methods: Observed survival of Australian patients commencing dialysis at 60y
or older from 1980–2012 extracted from ANZDATA Registry without censoring
for transplantation. Exponential parametric survival analysis used to model dialy-
sis patient survival. Matching age-, sex- and era-specific survival data extracted
from the Australian Bureau of Statistics Life Tables.
Results: The total number of patients 60y or older commencing dialysis
increased from 293 during 1980–82 to 4069 during 2010–2012, and the propor-
tion of patients in this cohort aged 60–64y fell from 60.1 to 21.0%. Over that
period the modelled median survival for those commencing dialysis at age 60
improved from 3.5–7.5y (114% increase) in men and women, compared with
general population improvements of 17.2–23.3y (35%) in men and 22.0–26.4y
(20%) in women. Similar relative survival gains were seen in dialysis cohorts
commencing up to 80 years of age however absolute gains were smaller and the
life expectancy gap is also increasing.
Conclusions: Modelled median survival is improving however the survival gap
between dialysis patients and the general population is significant (16.8 years at
age 60) and increasing. Further analysis is required to better define the relation-
ship between improving survival in the dialysis and general populations.
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THE PREVALENCE AND IMPACT OF PRURITIS IN
A DIALYSIS POPULATION
J HOLT1,3, S HERATH1, A LEE1,2, K MURALI1,3, M LONERGAN1,2,3,
K LAMBERT1
1Wollongong Hospital, NSW; 2Shoalhaven District Memorial Hospital, Nowra,
NSW; 3Shellharbour Hospital, NSW, Australia
Aim: To determine the prevalence and impact of pruritis in our dialysis
population.
Background: Itching is very common in patients who are on dialysis. Literature
regarding the impact of pruritis on quality of life and intensity of itch is limited.
Methods: The project was designed as a questionnaire. Local Ethics approval was
obtained. All patients on dialysis for ≥ 3 months area wide were eligible to
participate. Participants were approached by an investigator and asked a series of
questions. Routine blood results and lists of medications were also recorded.
Participants were asked to rate their itch in 3 different ways:
1. Visual Analogue Scale
2. Lund Browder chart to estimate total body surface area involved
3. Impact of itch on quality of life
Results: 127 patients were recruited over a 3 month period.114 patients were on
haemodialysis and 13 patients on peritoneal dialysis. The mean dialysis vintage
was 66.9 months and the mean duration of HD per week was 14.6 hours.
83 patients reported suffering with itch (63%) and, of these, only 35 (42%)
had informed their renal physician. The mean Visual Analogue reading was 31.7
and this method of rating itch did not correlate with any of the usual biochemical
parameters.
The mean body surface area involved was 18% and did not correlate with the
analogue reading.
The presence of itch significantly impacted on the ability to fall asleep, a
person’s appetite and their mood, with 69% reporting feeling unhappy either all
or most of the time.
Conclusions: Itch is common in patients undergoing dialysis and has a signifi-
cant impact on quality of life. The majority of patients do not report their
symptoms.
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NEUTROPHIL-LYMPHOCYTE RATIO AS A
MARKER OF INFLAMMATION AND PREDICTOR
OF MORTALITY IN PATIENTS WITH END-STAGE
KIDNEY DISEASE
BL NEUEN1, N LEATHER2, A GREENWOOD2, R GUNNARSSON2,
JP KILLEN1, RA BAER1, A NIGAM1, I ISMAIL1, L BERLUND1,
ML MANTHA1
1Department of Renal Medicine, Cairns Hospital, Cairns, QLD; 2School of
Medicine and Dentistry, James Cook University, Cairns, QLD, Australia
Aim: To examine the value of neutrophil-lymphocyte ratio (NLR) as a marker of
inflammation and predictor of all-cause mortality in patients with end-stage
kidney disease (ESKD).
Background: NLR is a marker of systemic inflammation that has been shown to
predict mortality in patients with coronary and peripheral vascular disease. In
contrast to albumin, NLR is unlikely to be affected by nutritional status. Its
prognostic value in ESKD patients is unclear.
Methods: We retrospectively reviewed all consecutive haemodialysis patients
between January 2007 and December 2011 at a single centre. We recorded
patient’s full blood count and other biochemistry three months after commence-
ment of dialysis. Correlations between NLR and other metabolic and inflamma-
tory markers were evaluated using Pearson’s r coefficient. The prognostic value of
NLR was tested using Kaplan Meier, univariate and multivariate Cox analyses
adjusted for Australian and New Zealand Dialysis and Transplant Registry data.
Results: 140 haemodialysis patients were included with median follow-up of 36
months and overall mortality of 41% (58 patients). Neutrophil-lymphocyte ratio
was positively correlated with C-reactive protein (r = 0.48, P < 0.01) and nega-
tively correlated with haemoglobin (r = −0.32, P < 0.01) and albumin (r = −0.40,
P < 0.01). In Kaplan Meier analysis, NLR (stratified into tertiles) was associated
with all-cause mortality (log-rank, P = 0.01). In multivariate Cox analysis, NLR
was independently associated with all-cause mortality (HR 1.09, 95% CI 1.01–
1.17 P = 0.03). Other predictors of all-cause mortality in multivariate analysis
were low albumin (HR 0.89, 95% CI 0.89–0.94 P < 0.01) and history of cardio-
vascular disease (HR 2.29, 95% CI 1.25–4.48 P = 0.01).
Conclusions: Neutrophil-lymphocyte ratio correlates with other markers of sys-
temic inflammation in ESKD patients and is associated with poor survival. The
extent to which other confounding factors affect these results is unknown.
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THE RELATIONSHIP BETWEEN PRE-DIALYSIS
SERUM AND DIALYSIS FLUID SODIUM
CONCENTRATIONS ON HAEMODIALYSIS
STABILITY
P SAGAR1, S SEN1,2
1Concord Repatriation General Hospital, Concord, NSW; 2University of Sydney,
Sydney, NSW, Australia
Aim: To audit the impact of using a single dialysis fluid sodium concentration
across a heterogenous haemodialysis patient population, in regards to
hemodynamic instability and interdialytic weight gain (IDWG).
Background: The current literature is mixed on the effect of matching pre-
dialysis serum sodium concentrations (sNa), to that of the dialysis fluid (dNa).
Some studies suggest that sodium-matched patients have better blood pressure
control and lower IDGW.
Methods: A retrospective analysis of 72 haemodialysis patients, who were
treated with a dNa of 140 mmol/L was performed. Data collected included base-
line demographics, comorbidities, average pre-dialysis serum electrolyte concen-
trations, dialysis prescription, and complication rates over the previous 3 months.
Results: The average sNa was 138 (range 129–143), with 75% less than 140
(low), 13% equal to 140 (equal), and 11% greater than 140 mmol/L (high). As
sNa increased, there was a non-significant decrease in IDWG (Low 2.0kg, Equal
1.71kgs, High 1.6kg; P = 0.25), and non-significant increases in hypotensive
episodes (low 1.9 events/session, equal 0.2, high 0.3; P = 0.55) and requirement
to decrease ultrafiltration volume (low 1.2 events/session, equal 0.1, high 0.1;
P = 0.52). There was no difference in age and gender between groups, nor with
analysis of sNa as a continuous variable.
Conclusions: Patients with a sNa lower than the dNa did not show significant
differences in IDWG, rates of intra-dialytic hypotension nor reduction in target
UF volumes. Small patient numbers and event rates may have obscured an actual
association, and further investigation is warranted.
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